|
SIL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.593800E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.539900E-03 |
| Normal-vs-Stage2 |
1.63150999999973E-05 |
| Normal-vs-Stage3 |
2.007900E-02 |
| Normal-vs-Stage4 |
4.175000E-01 |
| Stage1-vs-Stage2 |
1.767540E-04 |
| Stage1-vs-Stage3 |
9.916800E-01 |
| Stage1-vs-Stage4 |
3.254200E-01 |
| Stage2-vs-Stage3 |
2.398600E-03 |
| Stage2-vs-Stage4 |
5.975900E-04 |
| Stage3-vs-Stage4 |
3.415200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.863520E-03 |
| Normal-vs-AfricanAmerican |
4.825500E-02 |
| Normal-vs-Asian |
5.916800E-01 |
| Caucasian-vs-AfricanAmerican |
6.382800E-01 |
| Caucasian-vs-Asian |
8.320000E-02 |
| AfricanAmerican-vs-Asian |
1.158950E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.616200E-03 |
| Normal-vs-Female |
8.783100E-04 |
| Male-vs-Female |
4.706800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.571820E-02 |
| Normal-vs-Age(41-60Yrs) |
6.031500E-04 |
| Normal-vs-Age(61-80Yrs) |
4.319300E-03 |
| Normal-vs-Age(81-100Yrs) |
5.998400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.761000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.038800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.108000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.841600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.379400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.069600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.326300E-02 |
| Classical-VS-Follicular |
7.355800E-04 |
| Classical-VS-Other |
6.970400E-01 |
| Classical-VS-Normal |
3.853700E-02 |
| Tall-VS-Follicular |
2.399800E-04 |
| Tall-VS-Other |
5.802600E-01 |
| Tall-VS-Normal |
4.844600E-01 |
| Follicular-VS-Other |
1.891160E-01 |
| Follicular-VS-Normal |
1.99914999999828E-05 |
| Other-VS-Normal |
7.512800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.25760000027719E-07 |
| Normal-vs-N1 |
4.333800E-01 |
| N0-vs-N1 |
1.481820E-02 |
|
|
